INTRODUCTION: Mechanical circulatory support for @entity712 , including the @entity299 ( @entity299 , Syncardia, Tucson, AZ, USA) has increased in recent years. This report describes @entity548 complications associated with the device. METHODS: A single institution prospectively maintained quality improvement database was reviewed encompassing the first year of clinical experience with the @entity299 . @entity1 who underwent @entity299 implantation were identified, and a review of complications and outcomes was undertaken. RESULTS: Ten @entity1 underwent @entity299 implant. Four @entity1 experienced delayed @entity86 . In three @entity1 the manifestation of @entity548 was tamponade and evidenced by @entity299 decreased cardiac output. In two @entity1 , at postoperative days 31 and 137, there was a partial disruption of the aortic @entity254 along the outer curvature with @entity2849 formation. Both were repaired by primary suture closure, without use of cardiopulmonary bypass. There was no mortality attributable to @entity548 . CONCLUSIONS: @entity299 @entity1 are at risk for delayed @entity86 , often manifest as an acute decrease in cardiac output. Due to pulsatility and high dP/dT, @entity548 from the aortic @entity254 should be considered in the differential of a @entity1 with low flow and/or tamponade.

Late Surgical Bleeding Following XXXX Implantation.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity712 :: ('MESH:D006333', 'Disease') :: ['heart failure'] @entity548 :: ('MESH:D006470', 'Disease') :: ['bleeding'] @entity254 :: ('MESH:C563598', 'Disease') :: ['anastomosis'] @entity86 :: ('MESH:D019106', 'Disease') :: ['postoperative bleeding'] @entity299 :: ('MESH:D006331', 'Disease') :: ['TAH', 'Total Artificial Heart'] @entity2849 :: ('MESH:D017541', 'Disease') :: ['pseudoaneurysm']
@entity299 :: (MESH:D006331,Disease) :: ['Total Artificial Heart']
